ID   PABB_ECOLI              Reviewed;         453 AA.
AC   P05041;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   15-MAR-2017, entry version 148.
DE   RecName: Full=Aminodeoxychorismate synthase component 1;
DE            Short=ADC synthase;
DE            Short=ADCS;
DE            EC=2.6.1.85;
DE   AltName: Full=4-amino-4-deoxychorismate synthase component 1;
GN   Name=pabB; OrderedLocusNames=b1812, JW1801;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6330050;
RA   Goncharoff P., Nichols B.P.;
RT   "Nucleotide sequence of Escherichia coli pabB indicates a common
RT   evolutionary origin of p-aminobenzoate synthetase and anthranilate
RT   synthetase.";
RL   J. Bacteriol. 159:57-62(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9097040; DOI=10.1093/dnares/3.6.379;
RA   Itoh T., Aiba H., Baba T., Fujita K., Hayashi K., Inada T., Isono K.,
RA   Kasai H., Kimura S., Kitakawa M., Kitagawa M., Makino K., Miki T.,
RA   Mizobuchi K., Mori H., Mori T., Motomura K., Nakade S., Nakamura Y.,
RA   Nashimoto H., Nishio Y., Oshima T., Saito N., Sampei G., Seki Y.,
RA   Sivasundaram S., Tagami H., Takeda J., Takemoto K., Wada C.,
RA   Yamamoto Y., Horiuchi T.;
RT   "A 460-kb DNA sequence of the Escherichia coli K-12 genome
RT   corresponding to the 40.1-50.0 min region on the linkage map.";
RL   DNA Res. 3:379-392(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 42-377.
RC   STRAIN=ECOR 10, ECOR 16, and ECOR 8;
RX   PubMed=7896119;
RA   Guttman D.S., Dykhuizen D.E.;
RT   "Detecting selective sweeps in naturally occurring Escherichia coli.";
RL   Genetics 138:993-1003(1994).
RN   [6]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND NOMENCLATURE.
RX   PubMed=4914080;
RA   Huang M., Gibson F.;
RT   "Biosynthesis of 4-aminobenzoate in Escherichia coli.";
RL   J. Bacteriol. 102:767-773(1970).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-12, FUNCTION, CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=2251281; DOI=10.1073/pnas.87.23.9391;
RA   Ye Q.-Z., Liu J., Walsh C.T.;
RT   "p-aminobenzoate synthesis in Escherichia coli: purification and
RT   characterization of PabB as aminodeoxychorismate synthase and enzyme X
RT   as aminodeoxychorismate lyase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:9391-9395(1990).
RN   [8]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME REGULATION.
RX   PubMed=7592344; DOI=10.1128/jb.177.20.5918-5923.1995;
RA   Viswanathan V.K., Green J.M., Nichols B.P.;
RT   "Kinetic characterization of 4-amino 4-deoxychorismate synthase from
RT   Escherichia coli.";
RL   J. Bacteriol. 177:5918-5923(1995).
RN   [9]
RP   MUTAGENESIS OF GLY-275; ARG-311; ARG-316; SER-322 AND HIS-339, AND
RP   SUBUNIT.
RX   PubMed=8679677; DOI=10.1016/0167-4838(96)00029-5;
RA   Rayl E.A., Green J.M., Nichols B.P.;
RT   "Escherichia coli aminodeoxychorismate synthase: analysis of pabB
RT   mutations affecting catalysis and subunit association.";
RL   Biochim. Biophys. Acta 1295:81-88(1996).
RN   [10]
RP   MUTAGENESIS OF LYS-274, REACTION MECHANISM, ACTIVE SITE, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=14982443; DOI=10.1021/ja0389927;
RA   He Z., Stigers Lavoie K.D., Bartlett P.A., Toney M.D.;
RT   "Conservation of mechanism in three chorismate-utilizing enzymes.";
RL   J. Am. Chem. Soc. 126:2378-2385(2004).
RN   [11]
RP   ENZYME REGULATION.
RX   PubMed=15303852; DOI=10.1021/ja048312f;
RA   Bulloch E.M., Jones M.A., Parker E.J., Osborne A.P., Stephens E.,
RA   Davies G.M., Coggins J.R., Abell C.;
RT   "Identification of 4-amino-4-deoxychorismate synthase as the molecular
RT   target for the antimicrobial action of (6s)-6-fluoroshikimate.";
RL   J. Am. Chem. Soc. 126:9912-9913(2004).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF GLU-258 AND LYS-274,
RP   REACTION MECHANISM, ACTIVE SITE, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16605270; DOI=10.1021/bi052216p;
RA   He Z., Toney M.D.;
RT   "Direct detection and kinetic analysis of covalent intermediate
RT   formation in the 4-amino-4-deoxychorismate synthase catalyzed
RT   reaction.";
RL   Biochemistry 45:5019-5028(2006).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH TRYPTOPHAN,
RP   ACTIVE SITE, AND SUBUNIT.
RX   PubMed=11841211; DOI=10.1021/bi015791b;
RA   Parsons J.F., Jensen P.Y., Pachikara A.S., Howard A.J., Eisenstein E.,
RA   Ladner J.E.;
RT   "Structure of Escherichia coli aminodeoxychorismate synthase:
RT   architectural conservation and diversity in chorismate-utilizing
RT   enzymes.";
RL   Biochemistry 41:2198-2208(2002).
CC   -!- FUNCTION: Part of a heterodimeric complex that catalyzes the two-
CC       step biosynthesis of 4-amino-4-deoxychorismate (ADC), a precursor
CC       of p-aminobenzoate (PABA) and tetrahydrofolate. In the first step,
CC       a glutamine amidotransferase (PabA) generates ammonia as a
CC       substrate that, along with chorismate, is used in the second step,
CC       catalyzed by aminodeoxychorismate synthase (PabB) to produce ADC.
CC       PabB, in the absence of PabA, can catalyze the formation of ADC in
CC       the presence of exogenous ammonia. {ECO:0000269|PubMed:16605270,
CC       ECO:0000269|PubMed:2251281, ECO:0000269|PubMed:4914080}.
CC   -!- CATALYTIC ACTIVITY: Chorismate + L-glutamine = 4-amino-4-
CC       deoxychorismate + L-glutamate. {ECO:0000269|PubMed:16605270,
CC       ECO:0000269|PubMed:2251281}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:2251281};
CC   -!- ENZYME REGULATION: Inhibited by 6-diazo-5-oxo-L-norleucine (DON).
CC       The inhibition is competitive with glutamine but uncompetitive
CC       with chorismate. Also inhibited by 2-fluorochorismate.
CC       {ECO:0000269|PubMed:15303852, ECO:0000269|PubMed:7592344}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.2 uM for chorismate (with PabA and glutamine as the amino
CC         donor at pH 7.5) {ECO:0000269|PubMed:14982443,
CC         ECO:0000269|PubMed:16605270, ECO:0000269|PubMed:7592344};
CC         KM=18.6 uM for chorismate (with PabA and ammonia as the amino
CC         donor at pH 7.5) {ECO:0000269|PubMed:14982443,
CC         ECO:0000269|PubMed:16605270, ECO:0000269|PubMed:7592344};
CC         KM=71 uM for chorismate {ECO:0000269|PubMed:14982443,
CC         ECO:0000269|PubMed:16605270, ECO:0000269|PubMed:7592344};
CC         KM=75 uM for chorismate (with PabA)
CC         {ECO:0000269|PubMed:14982443, ECO:0000269|PubMed:16605270,
CC         ECO:0000269|PubMed:7592344};
CC         KM=379 uM for chorismate (with PabA and ammonia)
CC         {ECO:0000269|PubMed:14982443, ECO:0000269|PubMed:16605270,
CC         ECO:0000269|PubMed:7592344};
CC         KM=388 uM for chorismate (with ammonia)
CC         {ECO:0000269|PubMed:14982443, ECO:0000269|PubMed:16605270,
CC         ECO:0000269|PubMed:7592344};
CC   -!- PATHWAY: Cofactor biosynthesis; tetrahydrofolate biosynthesis; 4-
CC       aminobenzoate from chorismate: step 1/2.
CC   -!- SUBUNIT: Monomer. Heterodimer consisting of two non-identical
CC       subunits: a glutamine amidotransferase subunit (PabA) and a
CC       aminodeoxychorismate synthase subunit (PabB).
CC       {ECO:0000269|PubMed:11841211, ECO:0000269|PubMed:8679677}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene do not produce 4-
CC       aminobenzoate. {ECO:0000269|PubMed:4914080}.
CC   -!- MISCELLANEOUS: In this enzymatic reaction the C4 hydroxy group of
CC       chorismate is replaced by addition of a nucleophile at the C2
CC       position. The nucleophile is the epsilon-amino group of lysine 274
CC       transiently binds to C2 of chorismate (PubMed:16605270). PabB
CC       contains a tryptophan (Trp) molecule deeply embedded in a binding
CC       pocket. Trp which cannot be dissociated without denaturation of
CC       PabB, may play a structural role in the enzyme since it has no
CC       effect on the enzymic synthesis of aminodeoxychorismate
CC       (PubMed:11841211). {ECO:0000305|PubMed:11841211,
CC       ECO:0000305|PubMed:16605270}.
CC   -!- SIMILARITY: Belongs to the anthranilate synthase component I
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K02673; AAA24266.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC74882.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA15619.1; -; Genomic_DNA.
DR   EMBL; U07762; AAC43282.1; -; Genomic_DNA.
DR   EMBL; U07748; AAC43269.1; -; Genomic_DNA.
DR   EMBL; U07749; AAC43270.1; -; Genomic_DNA.
DR   PIR; A30251; AGEC1.
DR   RefSeq; NP_416326.1; NC_000913.3.
DR   PDB; 1K0E; X-ray; 2.00 A; A/B=1-453.
DR   PDB; 1K0G; X-ray; 2.05 A; A/B=1-453.
DR   PDBsum; 1K0E; -.
DR   PDBsum; 1K0G; -.
DR   ProteinModelPortal; P05041; -.
DR   SMR; P05041; -.
DR   BioGrid; 4260345; 170.
DR   DIP; DIP-10434N; -.
DR   IntAct; P05041; 6.
DR   STRING; 511145.b1812; -.
DR   DrugBank; DB01942; Formic Acid.
DR   PaxDb; P05041; -.
DR   PRIDE; P05041; -.
DR   EnsemblBacteria; AAC74882; AAC74882; b1812.
DR   EnsemblBacteria; BAA15619; BAA15619; BAA15619.
DR   GeneID; 946337; -.
DR   KEGG; ecj:JW1801; -.
DR   KEGG; eco:b1812; -.
DR   PATRIC; 32118943; VBIEscCol129921_1889.
DR   EchoBASE; EB0677; -.
DR   EcoGene; EG10683; pabB.
DR   eggNOG; ENOG4105CRQ; Bacteria.
DR   eggNOG; COG0147; LUCA.
DR   HOGENOM; HOG000025142; -.
DR   InParanoid; P05041; -.
DR   KO; K01665; -.
DR   OMA; SHQPWAM; -.
DR   PhylomeDB; P05041; -.
DR   BioCyc; EcoCyc:PABASYN-COMPI-MONOMER; -.
DR   BioCyc; MetaCyc:PABASYN-COMPI-MONOMER; -.
DR   BRENDA; 2.6.1.85; 2026.
DR   SABIO-RK; P05041; -.
DR   UniPathway; UPA00077; UER00149.
DR   EvolutionaryTrace; P05041; -.
DR   PRO; PR:P05041; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0046820; F:4-amino-4-deoxychorismate synthase activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0046656; P:folic acid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0046654; P:tetrahydrofolate biosynthetic process; IDA:UniProtKB.
DR   Gene3D; 3.60.120.10; -; 1.
DR   InterPro; IPR005801; ADC_synthase.
DR   InterPro; IPR019999; Anth_synth_I-like.
DR   InterPro; IPR006805; Anth_synth_I_N.
DR   InterPro; IPR015890; Chorismate_C.
DR   InterPro; IPR005802; Para-NH2Bz_synth_comp_1.
DR   Pfam; PF04715; Anth_synt_I_N; 1.
DR   Pfam; PF00425; Chorismate_bind; 1.
DR   PRINTS; PR00095; ANTSNTHASEI.
DR   SUPFAM; SSF56322; SSF56322; 1.
DR   TIGRFAMs; TIGR00553; pabB; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Folate biosynthesis; Magnesium; Reference proteome; Transferase.
FT   CHAIN         1    453       Aminodeoxychorismate synthase component
FT                                1.
FT                                /FTId=PRO_0000154136.
FT   REGION       43     46       Tryptophan binding.
FT   REGION      240    242       Tryptophan binding.
FT   ACT_SITE    258    258       Proton donor.
FT   ACT_SITE    274    274       N6-(4-deoxychorismate)-lysine
FT                                intermediate.
FT   BINDING      36     36       Tryptophan.
FT                                {ECO:0000269|PubMed:11841211}.
FT   MUTAGEN     258    258       E->A: The reaction is extremely slow.
FT                                {ECO:0000269|PubMed:16605270}.
FT   MUTAGEN     258    258       E->D: The reaction is extremely slow.
FT                                {ECO:0000269|PubMed:16605270}.
FT   MUTAGEN     274    274       K->A: Absence of covalent intermediate.
FT                                Addition of ammonia allows the formation
FT                                of the covalent intermediate and shows
FT                                that ammonia can replace the function of
FT                                K-274. Reduced catalytic efficiency.
FT                                {ECO:0000269|PubMed:14982443,
FT                                ECO:0000269|PubMed:16605270}.
FT   MUTAGEN     274    274       K->R: Absence of covalent intermediate.
FT                                {ECO:0000269|PubMed:14982443,
FT                                ECO:0000269|PubMed:16605270}.
FT   MUTAGEN     274    274       K->R: Reduced catalytic efficiency.
FT                                {ECO:0000269|PubMed:14982443,
FT                                ECO:0000269|PubMed:16605270}.
FT   MUTAGEN     275    275       G->S: Catalytically inactive for both the
FT                                glutamine-dependent and ammonia-dependent
FT                                reactions and fails to interact with
FT                                PabA. {ECO:0000269|PubMed:8679677}.
FT   MUTAGEN     311    311       R->K: Catalytically active in the NH3-
FT                                dependent, but inactive for the
FT                                glutamine-dependent reactions and fails
FT                                to complex with PabA.
FT                                {ECO:0000269|PubMed:8679677}.
FT   MUTAGEN     316    316       R->H: Catalytically inactive for both the
FT                                glutamine-dependent and ammonia-dependent
FT                                reactions and fails to interact with
FT                                PabA. {ECO:0000269|PubMed:8679677}.
FT   MUTAGEN     322    322       S->T: Complete loss of
FT                                aminodeoxychorismate synthase activity.
FT                                {ECO:0000269|PubMed:8679677}.
FT   MUTAGEN     339    339       H->W: Catalytically inactive for both the
FT                                glutamine-dependent and ammonia-dependent
FT                                reactions and fails to interact with
FT                                PabA. {ECO:0000269|PubMed:8679677}.
FT   STRAND        7     11       {ECO:0000244|PDB:1K0E}.
FT   HELIX        17     22       {ECO:0000244|PDB:1K0E}.
FT   TURN         23     27       {ECO:0000244|PDB:1K0E}.
FT   STRAND       32     35       {ECO:0000244|PDB:1K0E}.
FT   HELIX        42     44       {ECO:0000244|PDB:1K0G}.
FT   STRAND       46     50       {ECO:0000244|PDB:1K0E}.
FT   STRAND       54     60       {ECO:0000244|PDB:1K0E}.
FT   STRAND       63     68       {ECO:0000244|PDB:1K0E}.
FT   STRAND       71     75       {ECO:0000244|PDB:1K0E}.
FT   HELIX        79     89       {ECO:0000244|PDB:1K0E}.
FT   STRAND      104    110       {ECO:0000244|PDB:1K0E}.
FT   HELIX       112    117       {ECO:0000244|PDB:1K0E}.
FT   STRAND      133    146       {ECO:0000244|PDB:1K0E}.
FT   TURN        147    150       {ECO:0000244|PDB:1K0E}.
FT   STRAND      151    158       {ECO:0000244|PDB:1K0E}.
FT   HELIX       160    169       {ECO:0000244|PDB:1K0E}.
FT   STRAND      185    188       {ECO:0000244|PDB:1K0E}.
FT   HELIX       190    205       {ECO:0000244|PDB:1K0E}.
FT   STRAND      212    224       {ECO:0000244|PDB:1K0E}.
FT   HELIX       226    237       {ECO:0000244|PDB:1K0E}.
FT   STRAND      241    246       {ECO:0000244|PDB:1K0E}.
FT   STRAND      251    256       {ECO:0000244|PDB:1K0E}.
FT   STRAND      261    264       {ECO:0000244|PDB:1K0E}.
FT   STRAND      267    270       {ECO:0000244|PDB:1K0E}.
FT   STRAND      273    278       {ECO:0000244|PDB:1K0E}.
FT   TURN        297    301       {ECO:0000244|PDB:1K0E}.
FT   HELIX       302    314       {ECO:0000244|PDB:1K0E}.
FT   TURN        315    317       {ECO:0000244|PDB:1K0E}.
FT   STRAND      324    333       {ECO:0000244|PDB:1K0E}.
FT   STRAND      335    347       {ECO:0000244|PDB:1K0E}.
FT   HELIX       354    361       {ECO:0000244|PDB:1K0E}.
FT   HELIX       365    367       {ECO:0000244|PDB:1K0E}.
FT   STRAND      369    371       {ECO:0000244|PDB:1K0G}.
FT   HELIX       372    382       {ECO:0000244|PDB:1K0E}.
FT   STRAND      383    385       {ECO:0000244|PDB:1K0E}.
FT   TURN        388    391       {ECO:0000244|PDB:1K0E}.
FT   STRAND      392    398       {ECO:0000244|PDB:1K0E}.
FT   STRAND      403    406       {ECO:0000244|PDB:1K0E}.
FT   STRAND      410    415       {ECO:0000244|PDB:1K0E}.
FT   STRAND      418    427       {ECO:0000244|PDB:1K0E}.
FT   HELIX       433    451       {ECO:0000244|PDB:1K0E}.
SQ   SEQUENCE   453 AA;  50970 MW;  DBF17DD5E17289D8 CRC64;
     MKTLSPAVIT LLWRQDAAEF YFSRLSHLPW AMLLHSGYAD HPYSRFDIVV AEPICTLTTF
     GKETVVSESE KRTTTTDDPL QVLQQVLDRA DIRPTHNEDL PFQGGALGLF GYDLGRRFES
     LPEIAEQDIV LPDMAVGIYD WALIVDHQRH TVSLLSHNDV NARRAWLESQ QFSPQEDFTL
     TSDWQSNMTR EQYGEKFRQV QEYLHSGDCY QVNLAQRFHA TYSGDEWQAF LQLNQANRAP
     FSAFLRLEQG AILSLSPERF ILCDNSEIQT RPIKGTLPRL PDPQEDSKQA VKLANSAKDR
     AENLMIVDLM RNDIGRVAVA GSVKVPELFV VEPFPAVHHL VSTITAQLPE QLHASDLLRA
     AFPGGSITGA PKVRAMEIID ELEPQRRNAW CGSIGYLSFC GNMDTSITIR TLTAINGQIF
     CSAGGGIVAD SQEEAEYQET FDKVNRILKQ LEK
//
